{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Peripherally-Acting Mu-Opioid Receptor Antagonists
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on the use of peripherallyacting mu-opioid receptor (PAM-OR) antagonists to treat opioid-induced constipation (OIC).Learning Objectives
After completing this continuing education activity you will be able to:
- Recognize the effects of opioids and indications for PAM-OR antagonists.
- Select issues related to the administration of PAM-OR antagonists as well as potential adverse effects from those agents.
Disclosures
The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$15.00
Credits:
- ANCC 1.5 CH / 1.0 APH
- DC - BON 1.5 CH
- KY-BON 1.5 CH
- GA - BON 1.5 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: GN1117
Published: Nov/Dec 2017
Expires: 12/31/2026
Sources:
Gastroenterology Nursing
Required Passing Score: 14/19 (73%)
Categories:
Advanced Practice Nursing
,
Gastrointestinal
Specialties:
Gastroenterology